FDA Explores Use of Augmented Reality/Virtual Reality in Home Prototype

April 23, 2024

United StatesU.S. Executive Branch

Summary

On April 23, 2024, the FDA launched a new initiative, Home as a Health Care Hub, to advance health equity across the United States. Although many innovative care options seek to use the home as a virtual care site, few consider the critical elements of the home that are required for remote care, such as how different medical devices and technologies must work together. The agency is working with an architectural firm to design an Augmented Reality/Virtual Reality (AR/VR)-enabled home prototype, which will serve as an idea lab for connecting the populations most affected by health inequity with medical device developers, policymakers and providers. The FDA chose diabetes as the example health condition for the prototype given the “impacts over the lifecycle of someone living with this condition.”

Share This Page

Additional Information

Questions?

Email contacts@akingump.com for questions or additional insights.

Giving you full access to the latest in AI across regulatory developments, legal and policy issues, and industry news.

Akin Intelligence Newsletter

Subscribe to Akin Intelligence, our monthly newsletter recapping the latest in AI and its impact on various sectors. 

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.